Patents by Inventor Charles Ding

Charles Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11008345
    Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: May 18, 2021
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Vincent S. Hernandez, Charles Ding, Jacob J. Plattner, Michael Richard Kevin Alley, Fernando Rock, Suoming Zhang, Eric Easom, Xianfeng Li, Ding Zhou
  • Patent number: 10902430
    Abstract: Embodiments of the invention relate in part to determining a testing model and providing a testing transaction score for transactions. The testing transaction score may indicate a likelihood that the transaction is a testing transaction. One embodiment of the invention discloses a method comprising receiving a first authorization message for a first transaction using an account, determining a testing transaction score for the first transaction using a testing model, and determining that the first transaction is a testing transaction based on the testing transaction score, wherein the testing transaction score for the first transaction is used for declining a second transaction using the same account conducted after the first transaction.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: January 26, 2021
    Assignee: Visa International Service Association
    Inventors: Charles Ding, Aoyu Chen, Suyun Xu, Kevin Siegel
  • Publication number: 20200202315
    Abstract: Described are systems and methods for identifying and communicatively targeting financial devices to promote recurring transactions. The method includes receiving, with at least one processor, financial device data for a plurality of transactions over a sample time period, the financial device data including transaction time, transaction count, transaction amount, merchant category, transaction type, or any combination thereof. The method also includes identifying, with at least one processor, at least one target financial device from the financial device data based at least partially on at least one of the parameters having a value in a specified range for the at least one parameter. The method further includes receiving, with at least one processor, identification data of at least one target financial device holder, and automatically generating and transmitting at least one communication to the at least one target financial device holder.
    Type: Application
    Filed: May 12, 2017
    Publication date: June 25, 2020
    Inventors: Shankardas Mohandas, Charles Ding
  • Publication number: 20200175607
    Abstract: Segmentation algorithms may operate on vast quantities of data to segment the data into a useful data the model. The segmentation data model may then be applied to additional data that may be received in real time. Further, the real time data may be given a score based on the segmentation model and the desires of the user. The segmentation of the data and the score may be returned to a user and the user may determine if additional actions make logical sense based on the score and segmentation.
    Type: Application
    Filed: December 3, 2018
    Publication date: June 4, 2020
    Inventors: Charles Ding, Kebin Lu, Thomas Shieh
  • Publication number: 20200045131
    Abstract: A computer program product, system, and method for accessing an application from different locations to gather geo-location specific data via pre-provisioned network endpoints in the different locations, the method includes receiving a request from a client application to access an application via a particular geographical location to collect geo-location specific data via a pre-provisioned network endpoint in the particular location, selecting a route to send traffic via the particular geographical location using the pre-provisioned network endpoint, establishing a virtual circuit to route the request via a network endpoint, sending the request for execution to the network endpoint, collecting responses received from the network endpoint from accessing the application, and sending the responses to the client application.
    Type: Application
    Filed: July 31, 2019
    Publication date: February 6, 2020
    Applicant: Bungee Tech Corporation
    Inventors: Rajat Nigam, Ilya Polkovnichenko, Inez Raharjo, Charles Ding
  • Publication number: 20190345173
    Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.
    Type: Application
    Filed: July 30, 2019
    Publication date: November 14, 2019
    Inventors: VINCENT S. HERNANDEZ, CHARLES DING, JACOB J. PLATTNER, MICHAEL RICHARD KEVIN ALLEY, FERNANDO ROCK, SUOMING ZHANG, ERIC EASOM, XIANFENG LI, DING ZHOU
  • Publication number: 20190026743
    Abstract: Embodiments of the invention relate in part to determining a testing model and providing a testing transaction score for transactions. The testing transaction score may indicate a likelihood that the transaction is a testing transaction. One embodiment of the invention discloses a method comprising receiving a first authorization message for a first transaction using an account, determining a testing transaction score for the first transaction using a testing model, and determining that the first transaction is a testing transaction based on the testing transaction score, wherein the testing transaction score for the first transaction is used for declining a second transaction using the same account conducted after the first transaction.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 24, 2019
    Inventors: Charles DING, Aoyu CHEN, Suyun XU, Kevin SIEGEL
  • Patent number: 10134040
    Abstract: Embodiments of the invention relate in part to determining a testing model and providing a testing transaction score for transactions. The testing transaction score may indicate a likelihood that the transaction is a testing transaction. One embodiment of the invention discloses a method comprising receiving a first authorization message for a first transaction using an account, determining a testing transaction score for the first transaction using a testing model, and determining that the first transaction is a testing transaction based on the testing transaction score, wherein the testing transaction score for the first transaction is used for declining a second transaction using the same account conducted after the first transaction.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: November 20, 2018
    Assignee: Visa International Service Association
    Inventors: Charles Ding, Aoyu Chen, Suyun Xu, Kevin Siegel
  • Publication number: 20170355719
    Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.
    Type: Application
    Filed: August 24, 2017
    Publication date: December 14, 2017
    Inventors: Vincent S. Hernandez, Charles Ding, Jacob J. Plattner, Michael Richard Kevin Alley, Fernando Rock, Suoming Zhang, Eric Easom, Xianfeng Li, Ding Zhou
  • Patent number: 9751898
    Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: September 5, 2017
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Vincent S. Hernandez, Charles Ding, Jacob J. Plattner, Michael Richard Kevin Alley, Fernando Rock, Suoming Zhang, Eric Easom, Xianfeng Li, Ding Zhou
  • Publication number: 20140324699
    Abstract: Embodiments of the invention relate in part to determining a testing model and providing a testing transaction score for transactions. The testing transaction score may indicate a likelihood that the transaction is a testing transaction. One embodiment of the invention discloses a method comprising receiving a first authorization message for a first transaction using an account, determining a testing transaction score for the first transaction using a testing model, and determining that the first transaction is a testing transaction based on the testing transaction score, wherein the testing transaction score for the first transaction is used for declining a second transaction using the same account conducted after the first transaction.
    Type: Application
    Filed: April 28, 2014
    Publication date: October 30, 2014
    Inventors: Charles Ding, Aoyu Chen, Suyun Xu, Kevin Siegel
  • Publication number: 20140315860
    Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.
    Type: Application
    Filed: March 21, 2014
    Publication date: October 23, 2014
    Applicant: Anacor Pharmaceuticals, Inc.
    Inventors: Vincent S. HERNANDEZ, Charles Ding, Jacob J. Plattner, Michael Richard Kevin Alley, Fernando Rock, Suoming Zhang, Eric Easom, Xianfeng Li, Ding Zhou
  • Patent number: 8703742
    Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: April 22, 2014
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Vincent S. Hernandez, Charles Ding, Jacob J. Plattner, Michael Richard Kevin Alley, Fernando Rock, Suoming Zhang, Eric Easom, Xianfeng Li, Ding Zhou
  • Patent number: 8343944
    Abstract: This invention largely relates to 3,4,6-trisubstituted benzoxaborole compounds, and their use for treating bacterial infections.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: January 1, 2013
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Yi Xia, Michael Richard Kevin Alley, Yasheen Zhou, Rajeshwar Singh, Charles Ding, Kathy Cao, Jacob J. Plattner, Ligong Ou, Guofeng Jia, Neerja Saraswat, Sreekanth Ramachandran, Ding Zhou
  • Publication number: 20120115813
    Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.
    Type: Application
    Filed: September 7, 2011
    Publication date: May 10, 2012
    Applicant: Anacor Pharmaceuticals, Inc.
    Inventors: Vincent S. Hernandez, Charles Ding, Jacob J. Plattner, Michael Richard Kevin Alley, Fernando Rock, Suoming Zhang, Eric Easom, Xianfeng Li, Ding Zhou
  • Publication number: 20110136763
    Abstract: This invention largely relates to 3,4,6-trisubstituted benzoxaborole compounds, and their use for treating bacterial infections.
    Type: Application
    Filed: July 27, 2010
    Publication date: June 9, 2011
    Applicants: Anacor Pharmaceuticals, Inc., GlaxoSmithKline LLC
    Inventors: Yi Xia, Michael Richard Kevin Alley, Yasheen Zhou, Rajeshwar Singh, Charles Ding, Kathy Cao, Jacob J. Plattner, Ligong Ou, Guofeng Jia, Neerja Saraswat, Sreekanth Ramachandran, Ding Zhou
  • Publication number: 20110124597
    Abstract: This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
    Type: Application
    Filed: August 31, 2010
    Publication date: May 26, 2011
    Applicant: Anacor Pharmaceuticals, Inc.
    Inventors: Vincent S. HERNANDEZ, Charles DING, Jacob PLATTNER, Michael Richard Kevin ALLEY, Yong-Kang ZHANG, Yanchen ZHANG
  • Publication number: 20070287713
    Abstract: wherein Z1 is (CH2)q or C?O; Z2 is (CH2)p or C?O; D is —CH? or C?O or (CH2)m where m is 0, 1, 2 or 3; n=0, 1 or 2; p=1 or 2; q=0, 1 or 2; Q is C or N; A is (CH2)x where x is 1 to 5, or A is (CH2)x1, where x1 is 1 to 5 with an alkenyl bond or an alkynyl bond embedded anywhere in the chain, or A is —(CH2)x2—O—(CH2)x3— where x2 is 0 to 5 and x3 is 0 to 5, provided that at least one of x2 and x3 is other than 0; B is a bond or is (CH2)x4 where x4 is 1 to 5; X is CH or N; X2 is C, N, O or S; X3 is C, N, O or S; X4 is C, N, O or S; X5 is C, N, O or S; X6 is C, N, O or S; provided that at least one of X2, X3, X4 X5 and X6 is N; and at least one of X2, X3, X4 X5 and X6 is C. R1 is H or alkyl; R2 is H, alkyl, alkoxy, halogen, amino, substituted amino or cyano; R2a, R2b and R2c may be the same or different and are selected from H, alkyl, alkoxy, halogen, amino, substituted amino or cyano; and R3, E, Z and Y are as defined herein.
    Type: Application
    Filed: July 18, 2007
    Publication date: December 13, 2007
    Inventors: Peter Cheng, Sean Chen, Pratik Devasthale, Charles Ding, Timothy Herpin, Shung Wu, Hao Zhang, Wei Wang, Xiang-Yang Ye
  • Publication number: 20060019985
    Abstract: Novel rifamycin derivatives of formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or their salts, hydrates or prodrugs thereof, wherein: a preferred R comprises hydrogen, acetyl; L is a linker, a preferred linker group elements selected from any combination of 1 to 5 groups shown FIG. 1, provided L is not wherein R1 is H, methyl or alkyl. The inventive compounds exhibit valuable antibiotic properties. Formulations having these compounds can be used in the control or prevention of infectious diseases in mammals, both humans and non-humans. In particular, the compounds exhibit a pronounced antibacterial activity, even against multiresistant strains of microbes.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Applicant: Cumbre Inc.
    Inventors: Zhenkun Ma, Jing Li, Susan Harran, Yong He, Keith Minor, In Kim, Charles Ding, Jamie Longgood, Yafei Jin, Keith Combrink
  • Publication number: 20060019986
    Abstract: Rifamycin derivatives having the following structure of general formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or its salts, hydrates or prodrugs thereof; wherein a preferred R1 comprises hydrogen or acetyl and a prefered R2 comprises hydrogen, methyl or other lower alkyls; wherein asterik (*) denotes the carbon bearing the chiral center, wherein absolute configuration is assigned as R or S. Methods of preparation of the aforementioned rifamycin derivatives are also described. The compounds exhibit antimicrobial activities, including activities against drug-resistant microorganisms.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Applicant: Cumbre Inc.
    Inventors: Charles Ding, Zhenkun Ma, Jing Li, Susan Harran, Yong He, Keith Minor, In Kim, Jamie Longgood, Yafei Jin, Keith Combrink